Recombinant multi-species LC3/MAP1LC3B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LC3/MAP1LC3B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene is a subunit of neuronal microtubule-associated MAP1A and MAP1B proteins, which are involved in microtubule assembly and important for neurogenesis. Studies on the rat homolog implicate a role for this gene in autophagy, a process that involves the bulk degradation of cytoplasmic component. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1010001C15Rik,ATG8F,Atg8,Autophagy-related protein LC3 B,Autophagy-related ubiquitin-like modifier LC3 B,LC3,LC3B,LC3b,MAP1 light chain 3-like protein 2,MAP1A/1BLC3,MAP1A/MAP1B,MAP1A/MAP1B light chain 3 B),MAP1LC3B,MAP1LC3B-a,Map1lc3,Map1lc3b,Microtubule-associated protein 1 light chain 3 beta,Microtubule-associated proteins 1A/1B light chain 3B (MAP1A/MAP1B LC3 B,Mpl3,zbs559

Target products collectionGo to LC3/MAP1LC3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12566-Ag-1/ GM-Tg-hg-IP12566-Ag-2 Human LC3/MAP1LC3B protein Human
GM-Tg-rg-IP12566-Ag-1/ GM-Tg-rg-IP12566-Ag-2 Rat LC3/MAP1LC3B protein Rat
GM-Tg-mg-IP12566-Ag-1/ GM-Tg-mg-IP12566-Ag-2 Mouse LC3/MAP1LC3B protein Mouse
GM-Tg-cynog-IP12566-Ag-1/ GM-Tg-cynog-IP12566-Ag-2 Cynomolgus/Rhesus macaque LC3/MAP1LC3B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12566-Ag-1/ GM-Tg-felg-IP12566-Ag-2 Feline LC3/MAP1LC3B protein Feline
GM-Tg-cang-IP12566-Ag-1/ GM-Tg-cang-IP12566-Ag-2 Canine LC3/MAP1LC3B protein Canine
GM-Tg-bovg-IP12566-Ag-1/ GM-Tg-bovg-IP12566-Ag-2 Bovine LC3/MAP1LC3B protein Bovine
GM-Tg-equg-IP12566-Ag-1/ GM-Tg-equg-IP12566-Ag-2 Equine LC3/MAP1LC3B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12566-Ag-1/ GM-Tg-hg-IP12566-Ag-2; GM-Tg-rg-IP12566-Ag-1/ GM-Tg-rg-IP12566-Ag-2;
GM-Tg-mg-IP12566-Ag-1/ GM-Tg-mg-IP12566-Ag-2; GM-Tg-cynog-IP12566-Ag-1/ GM-Tg-cynog-IP12566-Ag-2;
GM-Tg-felg-IP12566-Ag-1/ GM-Tg-felg-IP12566-Ag-2; GM-Tg-cang-IP12566-Ag-1/ GM-Tg-cang-IP12566-Ag-2;
GM-Tg-bovg-IP12566-Ag-1/ GM-Tg-bovg-IP12566-Ag-2; GM-Tg-equg-IP12566-Ag-1/ GM-Tg-equg-IP12566-Ag-2
Products Name LC3/MAP1LC3B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LC3/MAP1LC3B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LC3/MAP1LC3B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.